MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine
By LabMedica International staff writers Posted on 05 Feb 2020 |

Illustration
Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre. As the MENA region’s largest medical laboratory exhibition and congress, MEDLAB Middle East plays a crucial role in developing the value of laboratory medicine in transforming tomorrow’s diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase new innovations, collaborate and network. MEDLAB Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 4th year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from over 135+ countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.
With laboratory services in the MEA region expected to grow at a compound annual growth rate (CAGR) of 3.8% until 2023, the 2020 edition of the show witnessed an increase in both the value of business and the number of attendees in comparison to last year. The four-day show organized by Informa Markets hosted the inaugural Transformation Hub, a dedicated zone showcasing advanced clinical laboratory products by the SMEs and new-to-market pioneers that are transforming diagnostics and advancing healthcare. The zone also featured the Transformation Talks sessions where manufacturers introduced new launches and in-demand solutions. Some of the key areas that were highlighted at the Transformation Hub included automation, healthcare information technology (HIT) and laboratory measurement testing and technology.
In addition to the Transformation Hub, MEDLAB Middle East also hosted a series of free-to-attend workshops, hosted by the National Reference Laboratory (NRL) and Bio-Rad, where a hands-on approach to learning and knowledge-sharing on new product offerings, technology and best practice took place. Workshops included Transfusion and blood typing challenges; Laboratory quality management system, the best of CLSI; and Laboratory accreditation, CAP updates.
MEDLAB Middle East also offered an educational agenda for clinical laboratory specialists to advance their skill sets, inspire and to provide advanced medical laboratory techniques for better health. More than 4,500 conference delegates had the opportunity to hear from 120 speakers from around the world, across 12 Continuing Medical Education (CME) accredited conferences.
The 2020 edition of the show saw the introduction of four new conference tracks, including Blood Transfusion Medicine, Laboratory Innovation, Digital Pathology and the Roundtable Discussions, which featured focused scientific group discussions on selected administration and technical topics in the medical laboratory.
“MEDLAB Middle East provides the ideal platform to showcase groundbreaking products to the medical laboratory industry here in the Middle East, while also sharing research and educational initiatives to visitors and delegates from around the word,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.
With laboratory services in the MEA region expected to grow at a compound annual growth rate (CAGR) of 3.8% until 2023, the 2020 edition of the show witnessed an increase in both the value of business and the number of attendees in comparison to last year. The four-day show organized by Informa Markets hosted the inaugural Transformation Hub, a dedicated zone showcasing advanced clinical laboratory products by the SMEs and new-to-market pioneers that are transforming diagnostics and advancing healthcare. The zone also featured the Transformation Talks sessions where manufacturers introduced new launches and in-demand solutions. Some of the key areas that were highlighted at the Transformation Hub included automation, healthcare information technology (HIT) and laboratory measurement testing and technology.
In addition to the Transformation Hub, MEDLAB Middle East also hosted a series of free-to-attend workshops, hosted by the National Reference Laboratory (NRL) and Bio-Rad, where a hands-on approach to learning and knowledge-sharing on new product offerings, technology and best practice took place. Workshops included Transfusion and blood typing challenges; Laboratory quality management system, the best of CLSI; and Laboratory accreditation, CAP updates.
MEDLAB Middle East also offered an educational agenda for clinical laboratory specialists to advance their skill sets, inspire and to provide advanced medical laboratory techniques for better health. More than 4,500 conference delegates had the opportunity to hear from 120 speakers from around the world, across 12 Continuing Medical Education (CME) accredited conferences.
The 2020 edition of the show saw the introduction of four new conference tracks, including Blood Transfusion Medicine, Laboratory Innovation, Digital Pathology and the Roundtable Discussions, which featured focused scientific group discussions on selected administration and technical topics in the medical laboratory.
“MEDLAB Middle East provides the ideal platform to showcase groundbreaking products to the medical laboratory industry here in the Middle East, while also sharing research and educational initiatives to visitors and delegates from around the word,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.
Latest MEDLAB 2020 News
- Diagnostica Stago Displays STA Compact Max and STA Satellite Max Analyzers at MEDLAB
- DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020
- GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB
- Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020
- New Technology that Detects MRSA in 15 Minutes Introduced at MEDLAB Middle East 2020
- Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB
- Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020
- EKF Diagnostics Displays POC Analyzers for Hemoglobin, HbA1c And Lactate at MEDLAB Middle East
- Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Revolutionary Blood Test Detects 30 Different Types of Cancers with 98% Accuracy
With cancer expected to become the leading cause of global mortality by 2030, early detection remains the most effective strategy to reduce death rates. Current screening methods only cover five types... Read more
Simple Blood Test Better Predicts Heart Disease Risk
Cardiovascular diseases (CVDs) are the primary cause of death worldwide. A large proportion of these cases could be prevented by addressing lifestyle and environmental factors such as smoking, poor diet,... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more